Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 6/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | GLP1R | P43220 | 7/20 | 0.37 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22737351 | 0.84 | FOLH1 (0.47) | NOD1FOLH1PRMT1GLP1R | |
| SCHEMBL18583123 | 0.82 | LMNA (0.44) | NOD1FOLH1ALDH1A1ENPEP | |
| SCHEMBL10699563 | 0.81 | FOLH1 (0.45) | FOLH1ALDH1A1ENPEP | |
| SCHEMBL24282431 | 0.80 | NOD1 (0.51) | NOD1FOLH1EPHX2GLP1R | |
| SCHEMBL29334247 | 0.78 | NOD1 (0.39) | NOD1FOLH1 | |
| SCHEMBL20341466 | 0.78 | FOLH1 (0.67) | FOLH1 | |
| SCHEMBL18164733 | 0.78 | FOLH1 (0.67) | FOLH1 | |
| SCHEMBL27325107 | 0.76 | FOLH1 (0.46) | NOD1FOLH1GLP1R | |
| SCHEMBL25548901 | 0.76 | MEN1 (0.53) | NOD1FOLH1EPHX2 | |
| SCHEMBL24135883 | 0.75 | C3AR1 (0.41) | NOD1FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200377549-A1 | PSMA Imaging Agents | SIEMENS MEDICAL SOLUTIONS USA, INC. | 2020-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200377549-A1 | PSMA Imaging Agents | FOLH1, KLK3, PSMA2 | NOD1 4292/4885FOLH1 1/4885PRMT1 1471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.